Introduction: Drawing on the amyloid/tau/neurodegeneration (AT[N]) model, the study examined whether the tau positron emission tomography (PET) biomarker [F]AV-1451 was associated with episodic memory problems beyond what was predicted by the amyloid beta (Aβ) PET in Down syndrome (DS).
Methods: Data from 123 non-demented adults with DS ( = 47 years, standard deviation = 6.34) were analyzed. The Cued Recall Test assessed episodic memory. Tau PET standardized update value ratio (SUVR) was assessed across Braak regions as continuous and binary (high tau [T] vs. low tau [T]) variable. Global PET Aβ SUVR was assessed as binary variable (Aβ- vs. Aβ+).
Results: In models adjusting for controls, tau SUVR was negatively associated with episodic memory performance in the Aβ+ but not Aβ- group. The Aβ+/T group evidenced significantly worse episodic memory than the Aβ+/T group.
Discussion: Similar to late-onset and autosomal dominant Alzheimer's disease (AD), high tau was an indicator of early prodromal AD in DS.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976157 | PMC |
http://dx.doi.org/10.1002/dad2.12256 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!